{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:10:57Z","timestamp":1760955057263},"reference-count":18,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.03.096","type":"journal-article","created":{"date-parts":[[2008,4,25]],"date-time":"2008-04-25T16:50:20Z","timestamp":1209142220000},"page":"5079-5082","source":"Crossref","is-referenced-by-count":11,"title":["Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Boberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gaunitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Br\u00e5ve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wahren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2008.03.096_bib1","first-page":"17","article-title":"HIV transmission and primary drug resistance","volume":"8","author":"Turner","year":"2006","journal-title":"AIDS Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.096_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/14712598.4.3.349","article-title":"Novel peptide-based HIV-1 immunotherapy","volume":"4","author":"Sommerfelt","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"21","key":"10.1016\/j.vaccine.2008.03.096_bib3","doi-asserted-by":"crossref","first-page":"10645","DOI":"10.1128\/JVI.01351-05","article-title":"Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic mice","volume":"80","author":"Okazaki","year":"2006","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2008.03.096_bib4","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1016\/j.vaccine.2005.08.019","article-title":"Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization","volume":"24","author":"Boberg","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.096_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1586\/14760584.6.2.203","article-title":"Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity","volume":"6","author":"Hinkula","year":"2007","journal-title":"Expert Rev Vac"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.096_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol Lett"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2008.03.096_bib7","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.096_bib8","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/1521-4141(2001010)31:10<3064::AID-IMMU3064>3.0.CO;2-L","article-title":"Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic H-2 class I KO mice","volume":"31","author":"Firat","year":"2001","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.096_bib9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.185.12.2043","article-title":"HLA-A2.1-restricted education and cytolytic activity of CD8 (+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice","volume":"185","author":"Pascolo","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.03.096_bib10","series-title":"Nonparametric Statistics for Health Care Research","author":"Pett","year":"1997"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.096_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/QAI.0b013e318074eb73","article-title":"Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study","volume":"46","author":"Costagliola","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.096_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.meegid.2007.01.009","article-title":"Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal","volume":"7","author":"Palma","year":"2007","journal-title":"Infect Genet Evol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.096_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2003.12.002","article-title":"Transmission of HIV-1 drug resistance","volume":"30","author":"Tang","year":"2004","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.096_bib14","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: fall 2006","volume":"14","author":"Johnson","year":"2006","journal-title":"Top HIV Med"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.096_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0264-410X(93)90039-Z","article-title":"Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems","volume":"11","author":"Holmgren","year":"1993","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.03.096_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0264-410X(94)90224-0","article-title":"Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit","volume":"12","author":"Oien","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.096_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0264-410X(88)90140-5","article-title":"Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit","volume":"6","author":"Tamura","year":"1988","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.096_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14760584.7.1.131","article-title":"Vaccination against drug resistance in HIV infection","volume":"7","author":"Boberg","year":"2008","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:09:40Z","timestamp":1631146180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":18,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X08003551"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.096","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}